Announcement on voluntary disclosure of clinical data for the PROTAC drug under development HP518 to be released at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.